AtriCure | ATRC - Ebit

Aktienkurs
29.28
Täglich Wechseln
1.07 3.79%
Monatlich
-0.85%
Jährlich
-12.34%
Q2 Prognose
28.65




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.51B 2026-03
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12